Home › Drugmaker GSK sees earnings growth returning in 2016
 

Keywords :   


Drugmaker GSK sees earnings growth returning in 2016

2015-07-29 15:23:07| Biotech - Topix.net

Britain-based drugmaker GlaxoSmithKline has reported a drop in earnings in the first full quarter since its deal to swap some assets with Swiss rival Novartis. Second-quarter net income fell to 149 million pounds from 654 million pounds a year earlier, while sales rose 6 percent to 5.89 billion pounds.

Tags: growth returning sees earnings

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.09Atlantic Tropical Weather Outlook
22.09Eastern North Pacific Tropical Weather Outlook
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
More »